CA-JUNIPER-NETWORKS
25.5.2022 09:02:36 CEST | Business Wire | Press release
NEC Corporation (NEC; TSE: 6701), a leading global IT and network transformation services provider, and Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced they have worked with Algeria Telecom, the leader in the Algerian telecommunications market, to roll out its modernized, nationwide IP metro commercial network to support current demand for increased capacity as well as future needs driven by 5G and FTTx.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220524005904/en/
Algeria Telecom has formed a mid-term strategic plan to implement a transport network with a homogenized, optimized topology as well as automation capabilities that guarantee bandwidth and future-proofing of its infrastructure in a growing market. NEC and Juniper have successfully delivered Algeria Telecom’s next generation IP metro network while ensuring quality of service, driving toward the best possible user experience, at scale.
As the innovative foundation of the new platform, Algeria Telecom has selected high-performing, secure solutions from the Juniper Networks portfolio for SDN-ready, cloud-grade networking and feature-rich, simple and secure connectivity at scale, deployed as access nodes to create separate pre-aggregation, aggregation and access domains for optimal reliability. Elements of the Juniper Paragon Automation cloud-native solution suite, Paragon Pathfinder and Paragon Planner have been deployed, enabling Algeria Telecom to achieve deep visibility and simplified operations of its network and services. This paves the way for assured user experiences within complex 5G and multicloud services. All of the Juniper platforms run on a single operating system, Junos® OS , to create an easily-managed, simplified and open solution.
NEC leveraged its extensive transport network integration and engineering capabilities to skillfully deliver best-in-class solutions that are dynamically tailored for Algeria Telecom’s requirements. Moreover, NEC orchestrated the total project as a ‘One-Stop Network Integrator’, capitalizing on its professional services based on global and local experiences ranging from network analysis and consulting, to design, implementation, migration and operation of high-capacity networks.
In addition, NEC and Juniper’s solid partnership, built on a track record of delivering innovative networking to hundreds of customers across the globe, has enabled the tight coordination between the parties to achieve Algeria Telecom’s objective of providing a high-capacity innovative network to accommodate surging data traffic and a future of diversified 5G use cases.
"The successful completion of the IP metro network modernization project by our partners, NEC Corporation and Juniper Networks, will allow us to make the migration to IPV6 and the initiation of digital transformation, as well as the implementation of high speed internet, as we best satisfy the needs of Algeria Telecom customers," said Mr. Adel Bentoumi, CEO of Algeria Telecom.
“The rapid growth of network traffic is a clear indication of the need for modernization and expansion of network capacity,” said Allahoum Hocine, Head of IP Core, Algeria Telecom. “NEC and Juniper have been extremely attentive to our needs, both technical and commercial, working as an extension of our team with their outstanding local engineering abilities, as well as their relentless efforts to assure quality of experience and on-time delivery. Overall, the innovative solutions from Juniper to enable this automated metro cloud architecture have helped us achieve our strategic goals and thrive as we pave the way for 5G.”
“Networks have always been a key asset for service providers, but going forward they will be the foundation for every aspect of business transformation in the 5G and cloud era. Algeria Telecom is jumping ahead of the curve by investing in an open, agile and automated network architecture that can drive simplified operations, improved economics and superior end-user experiences,” said Brendan Gibbs, Senior Vice President, Automated WAN Solutions, Juniper Networks.
“Our customer-first approach and uncompromising quality are values that are deeply ingrained in our culture,” said Hideyuki Ogata, General Manager, Service Provider Solutions Department, NEC Corporation. “This, combined with our accumulated domain expertise at NEC 5G Transport Network Center of Excellence (CoE) in EMEA, makes us confident that our extended engagement through this partnership will help enable continuous success and advancement of Algeria Telecom’s business.”
Additional Resources:
The NEC-Juniper Global Alliance
About Algeria Telecom
Algeria Telecommunications Corporation (French: Algérie Télécom) is the state owned telecom operator in Algeria. It is a public company active in the fields of fixed phone and internet. Algérie Télécom was created on 5 August 2000.
For more information, visit Algeria Telecom at www.algerietelecom.dz
About Juniper Networks
Juniper Networks is dedicated to dramatically simplifying network operations and driving superior experiences for end users. Our solutions deliver industry-leading insight, automation, security and AI to drive real business results. We believe that powering connections will bring us closer together while empowering us all to solve the world’s greatest challenges of well-being, sustainability and equality. Additional information can be found at Juniper Networks (www.juniper.net ) or connect with Juniper on Twitter , LinkedIn and Facebook .
Juniper Networks, the Juniper Networks logo, Juniper, Junos, and other trademarks listed here are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.
About NEC Corporation
NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at http://www.nec.com .
LinkedIn
: https://www.linkedin.com/company/nec/
YouTube
: https://www.youtube.com/user/NECglobalOfficial
Facebook
: https://www.facebook.com/nec.global/
Twitter
: https://twitter.com/NEC_corp
NEC is a registered trademark of NEC Corporation. All Rights Reserved. Other product or service marks mentioned herein are the trademarks of their respective owners. ©2022 NEC Corporation.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220524005904/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom